Top Biotech companies by Market Cap
Browse the largest Biotech companies in the world ranked by their Market Capitalization. Global Biotech Companies market cap is $8.02T.
10 Oct 2024, 10:53 UTC
Companies: 2380
๐บ๐ธ1 | $912.87 | 0.87% | 866.59B | 57.28% | Outperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐ฉ๐ฐ2 | $134.85 | 2.11% | 604.51B | 32.58% | Outperform S&P500 YTD Benchamark | โ๏ธ Healthcare | 0.78% | |
๐บ๐ธ3 | $165.25 | -0.54% | 397.77B | 5.30% | Underperform S&P500 YTD Benchamark | โ๏ธ Healthcare | - | |
๐บ๐ธ4 | $193.78 | 0.44% | 342.13B | 25.10% | Outperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐บ๐ธ5 | $117.28 | -1.15% | 297.19B | 7.44% | Underperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐จ๐ญ6 | $39.42 | -0.48% | 251.86B | 9.26% | Underperform S&P500 YTD Benchamark | ๐ Pharma | 3.56% | |
๐ฌ๐ง7 | $79.25 | 0.85% | 245.70B | 18.57% | Outperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐บ๐ธ8 | $623.50 | 2.19% | 240.90B | 17.74% | Underperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐จ๐ญ9 | $116.24 | 0.41% | 238.92B | 13.78% | Underperform S&P500 YTD Benchamark | ๐ Pharma | 3.04% | |
๐บ๐ธ10 | $278.01 | 2.25% | 205.43B | 20.95% | Outperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐บ๐ธ11 | $337.12 | 1.26% | 180.42B | 17.35% | Underperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐บ๐ธ12 | $29.74 | -0.03% | 167.92B | 2.98% | Underperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐ฆ๐บ13 | $199.60 | -0.20% | 149.68B | 3.28% | Underperform S&P500 YTD Benchamark | ๐งฌ Biotech | 1.27% | |
๐ซ๐ท14 | $58.19 | 1.25% | 145.93B | 17.98% | Underperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐บ๐ธ15 | $1,162.00 | 2.04% | 124.48B | 32.97% | Outperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐บ๐ธ16 | $474.16 | -1.48% | 122.19B | 17.08% | Underperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐บ๐ธ17 | $83.08 | -0.10% | 103.52B | 2.68% | Underperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐บ๐ธ18 | $49.49 | -1.00% | 100.70B | -3.81% | Underperform S&P500 YTD Benchamark | ๐ Pharma | 4.71% | |
๐บ๐ธ19 | $196.48 | 0.39% | 90.61B | 0.35% | Underperform S&P500 YTD Benchamark | โ๏ธ Healthcare | 0.76% | |
๐ฌ๐ง20 | $21.17 | -0.34% | 87.13B | 9.85% | Underperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐ฏ๐ต21 | $47.53 | -1.65% | 78.15B | 27.27% | Outperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐ฏ๐ต22 | $34.45 | -1.47% | 66.04B | 24.18% | Outperform S&P500 YTD Benchamark | ๐ Pharma | 0.58% | |
๐ฐ๐ท23 | $750.10 | 1.96% | 53.39B | 30.26% | Outperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐ฎ๐ณ24 | $22.11 | 0.79% | 53.08B | 46.74% | Outperform S&P500 YTD Benchamark | ๐ Pharma | 0.57% | |
๐จ๐ญ25 | $630.77 | -0.96% | 46.85B | 50.90% | Outperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐ฏ๐ต26 | $29.61 | -0.05% | 45.94B | 2.26% | Underperform S&P500 YTD Benchamark | ๐ Pharma | 4.28% | |
๐ฉ๐ช27 | $50.51 | 2.37% | 45.09B | -7.28% | Underperform S&P500 YTD Benchamark | ๐งช Chemical | - | |
๐บ๐ธ28 | $511.30 | -0.19% | 42.46B | -6.77% | Underperform S&P500 YTD Benchamark | โ๏ธ Healthcare | - | |
๐บ๐ธ29 | $140.29 | 1.40% | 41.25B | 1.52% | Underperform S&P500 YTD Benchamark | ๐ป Tech | 0.64% | |
๐จ๐ณ30 | $6.36 | 0.78% | 40.58B | -0.27% | Underperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐จ๐ณ31 | $32.17 | -1.50% | 39.01B | -21.48% | Underperform S&P500 YTD Benchamark | ๐ฉน Medical devices | - | |
๐บ๐ธ32 | $215.48 | 0.32% | 34.70B | 12.72% | Underperform S&P500 YTD Benchamark | ๐จโ๐ป Software | - | |
๐จ๐ญ33 | $130.14 | -0.85% | 34.57B | 26.81% | Outperform S&P500 YTD Benchamark | โ๏ธ๐ป Healthtech | - | |
๐บ๐ธ34 | $274.95 | 0.18% | 34.34B | 44.80% | Outperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐ง๐ช35 | $178.23 | 0.66% | 33.81B | 101.70% | Outperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐ณ๐ฑ36 | $529.07 | 1.31% | 31.32B | 40.11% | Outperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐ฐ๐ท37 | $147.90 | -0.20% | 30.66B | -4.08% | Underperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐ฉ๐ช38 | $31.05 | 1.67% | 30.50B | -17.37% | Underperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐ฏ๐ต39 | $55.37 | -2.19% | 30.05B | 46.44% | Outperform S&P500 YTD Benchamark | ๐ Pharma | 1.30% | |
๐บ๐ธ40 | $197.53 | -0.34% | 28.58B | -23.31% | Underperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐ฉ๐ช41 | $115.55 | -7.41% | 27.47B | 9.87% | Underperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐บ๐ธ42 | $69.86 | -2.96% | 26.64B | -30.06% | Underperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐บ๐ธ43 | $68.97 | -1.60% | 26.62B | -44.00% | Underperform S&P500 YTD Benchamark | โ๏ธ๐ป Healthtech | - | |
๐ฎ๐ช44 | $302.45 | 3.39% | 24.90B | 7.81% | Underperform S&P500 YTD Benchamark | ๐ป Tech | - | |
๐ฉ๐ช45 | $184.56 | -0.39% | 23.85B | 14.92% | Underperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐ฏ๐ต46 | $11.94 | 0.41% | 21.72B | -1.19% | Underperform S&P500 YTD Benchamark | ๐ Pharma | 3.25% | |
๐บ๐ธ47 | $123.46 | -0.44% | 21.10B | -2.79% | Underperform S&P500 YTD Benchamark | ๐ Real estate | 4.02% | |
๐บ๐ธ48 | $130.97 | 0.58% | 20.80B | -5.02% | Underperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐บ๐ธ49 | $81.72 | -0.34% | 20.17B | 15.03% | Underperform S&P500 YTD Benchamark | โ๏ธ Healthcare | - | |
๐ฎ๐ฑ50 | $17.88 | 0.17% | 20.01B | 70.77% | Outperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐บ๐ธ51 | $39.37 | -1.11% | 19.92B | 2.34% | Underperform S&P500 YTD Benchamark | โ๏ธ Healthcare | 2.94% | |
๐บ๐ธ52 | $328.97 | 0.10% | 19.45B | 0.43% | Underperform S&P500 YTD Benchamark | ๐ป Tech | - | |
๐บ๐ธ53 | $227.22 | 0.09% | 19.29B | 0.27% | Underperform S&P500 YTD Benchamark | โ๏ธ Healthcare | - | |
๐บ๐ธ54 | $27.06 | 0.71% | 18.30B | 19.31% | Outperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐จ๐ญ55 | $40.93 | -0.35% | 17.64B | 27.90% | Outperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐ฎ๐ณ56 | $65.35 | 0.31% | 17.35B | 39.88% | Outperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐บ๐ธ57 | $24.56 | -6.33% | 17.21B | 851.94% | Outperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐ฉ๐ฐ58 | $26.20 | -0.87% | 17.11B | -16.43% | Underperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐บ๐ธ59 | $342.59 | -0.70% | 16.10B | 55.92% | Outperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐ฎ๐ณ60 | $19.71 | -1.21% | 15.91B | 31.87% | Outperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐บ๐ธ61 | $124.54 | 1.49% | 15.37B | 14.37% | Underperform S&P500 YTD Benchamark | โ๏ธ Healthcare | - | |
๐บ๐ธ62 | $127.10 | -0.09% | 15.27B | 106.06% | Outperform S&P500 YTD Benchamark | โ๏ธ Healthcare | - | |
๐จ๐ณ63 | $2.57 | 2.30% | 15.25B | 27.22% | Outperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐ฌ๐ง64 | $11.07 | -0.83% | 15.22B | 7.21% | Underperform S&P500 YTD Benchamark | ๐ป Tech | - | |
๐จ๐ณ65 | $5.75 | 1.65% | 14.74B | -44.24% | Underperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐บ๐ธ66 | $65.17 | -1.90% | 14.57B | 4.46% | Underperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐บ๐ธ67 | $11.90 | 0.68% | 14.28B | 10.29% | Underperform S&P500 YTD Benchamark | โ๏ธ Healthcare | - | |
๐ซ๐ท68 | $119.19 | -0.60% | 14.08B | 6.57% | Underperform S&P500 YTD Benchamark | โ๏ธ Healthcare | - | |
๐ฎ๐ณ69 | $40.12 | -0.05% | 13.58B | 44.43% | Outperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐บ๐ธ70 | $71.14 | 0.84% | 13.40B | -26.24% | Underperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐ฏ๐ต71 | $44.79 | 1.38% | 13.34B | -6.14% | Underperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐ฎ๐ณ72 | $12.89 | -2.79% | 13.09B | 56.95% | Outperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐ฎ๐ณ73 | $78.48 | -0.96% | 13.03B | 13.24% | Underperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐บ๐ธ74 | $28.21 | -0.11% | 12.63B | 0.79% | Underperform S&P500 YTD Benchamark | ๐งฌ Biotech | 2.84% | |
๐ฏ๐ต75 | $22.89 | -0.46% | 12.30B | 36.07% | Outperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐บ๐ธ76 | $67.99 | -2.14% | 12.30B | -7.50% | Underperform S&P500 YTD Benchamark | โ๏ธ Healthcare | - | |
๐จ๐ณ77 | $9.67 | 0.91% | 12.27B | -9.13% | Underperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐บ๐ธ78 | $76.51 | 1.63% | 12.03B | 0.17% | Underperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐บ๐ธ79 | $7.41 | 8.81% | 12.00B | 346.39% | Outperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐ฎ๐ณ80 | $26.04 | -2.07% | 11.84B | 64.58% | Outperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐บ๐ธ81 | $119.85 | -2.01% | 11.78B | -7.95% | Underperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐บ๐ธ82 | $125.01 | -0.54% | 11.69B | 30.90% | Outperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐ฏ๐ต83 | $40.59 | 2.91% | 11.64B | -18.43% | Underperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐ฎ๐น84 | $55.91 | 0.10% | 11.52B | 2.65% | Underperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐ฎ๐ณ85 | $28.62 | -2.44% | 11.47B | 20.38% | Outperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐บ๐ธ86 | $116.54 | -0.18% | 11.09B | 87.94% | Outperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐บ๐ธ87 | $361.29 | 1.87% | 11.09B | 18.76% | Outperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐บ๐ธ88 | $60.32 | -0.05% | 10.92B | 35.58% | Outperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐ธ๐ช89 | $32.13 | -1.38% | 10.91B | 22.30% | Outperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐ฎ๐ณ90 | $18.37 | -0.86% | 10.77B | 41.85% | Outperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐บ๐ธ91 | $206.10 | -0.05% | 10.57B | -12.13% | Underperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐บ๐ธ92 | $72.87 | -0.53% | 10.42B | 136.59% | Outperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐ซ๐ท93 | $121.15 | -1.62% | 10.02B | 0.74% | Underperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐ฉ๐ช94 | $275.76 | 1.27% | 9.43B | -27.03% | Underperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐บ๐ธ95 | $66.81 | 2.74% | 9.25B | -8.10% | Underperform S&P500 YTD Benchamark | ๐ป Tech | - | |
๐บ๐ธ96 | $49.91 | -2.46% | 9.10B | -16.06% | Underperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐จ๐ณ97 | $5.63 | -0.79% | 9.06B | 3.18% | Underperform S&P500 YTD Benchamark | ๐งฌ Biotech | - | |
๐ฎ๐ณ98 | $74.21 | -2.21% | 8.87B | 19.33% | Outperform S&P500 YTD Benchamark | ๐ Pharma | - | |
๐บ๐ธ99 | $135.70 | 1.11% | 8.85B | 25.58% | Outperform S&P500 YTD Benchamark | ๐ด Food | - | |
๐ฐ๐ท100 | $67.58 | 1.13% | 8.70B | 75.25% | Outperform S&P500 YTD Benchamark | ๐ญ Manufacturing | - |